Rexahn and TheraTarget Form Nanotechnology Research Collaboration

Under the terms of the agreement, TheraTarget will synthesize and supply Rexahn with polymer-drug conjugate products, which are part of Rexahn's polymer-based nanomedicine portfolio.

Related Posts

Comments are closed.